{"id":7745,"date":"2020-01-08T09:00:30","date_gmt":"2020-01-08T14:00:30","guid":{"rendered":"https:\/\/www.singlecare.com\/blog\/?p=7745"},"modified":"2021-04-16T14:51:45","modified_gmt":"2021-04-16T18:51:45","slug":"new-drugs-2020","status":"publish","type":"post","link":"https:\/\/www.singlecare.com\/blog\/news\/new-drugs-2020\/","title":{"rendered":"Learn about 5 new drugs coming in 2020"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Since 2010 the number of new drugs approved each year by the U.S. Food and Drug Administration (FDA) has increased dramatically, averaging more than 38 new approvals each year compared to previous averages closer to 21. This is great news for patients, as the availability of new drugs and biological products usually means more treatment options for the people who need them most.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Of the new drugs approved each year, some are innovative products that have never been used before, while others are related to (if not the same as) other drugs already available and will compete in the marketplace. The latter are usually newly available thanks to the expiration of patents, allowing for more options and generic versions of the medication to be sold commercially.\u00a0<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">How are drugs approved by the FDA?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">The FDA\u2019s Center for Drug Evaluation and Research (<\/span><a href=\"https:\/\/www.fda.gov\/about-fda\/office-medical-products-and-tobacco\/center-drug-evaluation-and-research-cder\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">CDER<\/span><\/a><span style=\"font-weight: 400;\">) is responsible for approving and evaluating new drugs before they are available to the public. According to the <\/span><a href=\"https:\/\/www.fda.gov\/drugs\/development-approval-process-drugs\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">FDA<\/span><\/a><span style=\"font-weight: 400;\">, the CDER ensures that both brand-name and generic drugs \u201cwork correctly, and that their health benefits outweigh their own risks.\u201d\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The process pharmaceutical companies must go through in order to achieve FDA approval, and in turn start selling their drugs, is long and structured. It can take up to <\/span><a href=\"https:\/\/www.drugs.com\/fda-approval-process.html\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">two and a half years<\/span><\/a><span style=\"font-weight: 400;\"> for the FDA to approve a new drug, which is on top of the years researchers take to develop the drug and run clinical trials. In some cases, such as for therapies that treat life-threatening diseases, the FDA will expedite the process through Accelerated Approval.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">There are essentially three stages to the FDA approval process.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">1. Analysis of the target condition and available treatments<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">The FDA analyzes the illness or condition that the drug or product is intended to treat. In doing so, it also evaluates the current treatment landscape of the condition to effectively weigh the drug\u2019s potential benefits and risks.\u00a0<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">2. Assessments of benefits and risks from clinical data<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">In most circumstances, drug makers have to submit results of at least two clinical trials. The FDA uses this data to evaluate the risks and benefits of the drug.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">3. Strategies for managing risks<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">As all drugs have risks, it is essential that drugmakers have a plan to manage them. This can include an FDA-approved drug label that clearly details all risks and benefits, as well as how to mitigate them, but can also extend to more in-depth and comprehensive strategies.\u00a0<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">What happens when the FDA approves a drug?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">If a drug is successfully approved for sale by the FDA, the time it takes to hit the market and become available to patients can vary significantly. Often it comes down to how quickly a company can create and prepare all the necessary marketing materials, including packaging, educational, and promotional materials that all pass regulatory approval.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Depending on the specific drug\u2014for example, a generic can usually go to market much faster than a brand new, innovative drug\u2014and resources of the drug company, some drugs are available for purchase within weeks of approval, while others require months or longer.\u00a0<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">New drugs for 2020<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">With all that in mind, it\u2019s no small feat that a number of new drugs will be available to patients in 2020. Some, of course, we don\u2019t know of yet, as they will be approved and ready for sale over the next 12 months. This is a list of five of the new drugs the FDA approved in 2019 that are being prepared for availability in 2020.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Oxbryta (voxelotor)<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">This <\/span><a href=\"https:\/\/www.oxbryta.com\/\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">new drug<\/span><\/a><span style=\"font-weight: 400;\"> is used to treat sickle cell anemia, a life-threatening, inherited blood disease that deforms red blood cells. The sickle shaped cells prevent oxygen from being transported effectively throughout the body. Oxbryta works by inhibiting the central abnormality in sickle cells, which can lead to a much needed increase in hemoglobin levels.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Oxbryta is an example of a drug that was granted Accelerated Approval <\/span><a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-novel-treatment-target-abnormality-sickle-cell-disease\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">on November 25, 2019<\/span><\/a><span style=\"font-weight: 400;\">. It took only two weeks for the drug to come to market. As of December 2019, it is available for use in patients over 12 years of age with sickle cell anemia. It will be made more readily available with increased distribution throughout 2020.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Taken <\/span><a href=\"https:\/\/www.oxbryta.com\/pdf\/prescribing-information.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">once daily<\/span><\/a><span style=\"font-weight: 400;\"> as an oral tablet, Oxbryta\u2019s list price is $10,417 per month. It\u2019s considered a breakthrough drug for the disease, as it treats the root cause of sickle cell anemia rather than just managing symptoms.\u00a0<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Brukinsa (zanubrutinib)<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Another drug that was granted expedited approval by the <\/span><a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-therapy-treat-patients-relapsed-and-refractory-mantle-cell-lymphoma-supported-clinical\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">FDA<\/span><\/a><span style=\"font-weight: 400;\"> in November 2019 was Brukinsa, a drug used to treat adult patients with mantle cell lymphoma. Patients, however, must have tried at least one other therapy before transitioning to Brukinsa.\u00a0\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Drugmaker BeiGene USA received the FDA approval for Brukinsa and will compete with other medications including first-to-market <\/span><a href=\"https:\/\/www.singlecare.com\/prescription\/imbruvica\"><span style=\"font-weight: 400;\">Imbruvica<\/span><\/a><span style=\"font-weight: 400;\">.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Currently priced at $12,935 for a 30-day supply, Brukinsa can be taken daily or twice daily. The medication is currently undergoing further clinical trials in an attempt to gain second approval as a treatment for chronic lymphocytic leukemia. BeiGene recently <\/span><a href=\"http:\/\/ir.beigene.com\/news-releases\/news-release-details\/beigene-announces-clinical-data-brukinsatm-zanubrutinib-61st\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">released data<\/span><\/a><span style=\"font-weight: 400;\"> which shows promise.\u00a0<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Roflumilast<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Roflumilast is the generic version of <\/span><a href=\"https:\/\/www.singlecare.com\/prescription\/daliresp\"><span style=\"font-weight: 400;\">Daliresp<\/span><\/a><span style=\"font-weight: 400;\"> and is likely to become available in 2020. The drug is used to treat patients with severe chronic obstructive pulmonary disease (COPD).\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Generally, it\u2019s great news for consumers when a generic becomes available, as a generic can lower the cost of medication by up to 85%. But, although the manufacturer (Breckenridge Pharmaceutical, Inc) received FDA approval, there is no guarantee when it will become commercially available, due to drug exclusivity and patents.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Other drugs sometimes used to treat COPD include bronchodilators like <\/span><a href=\"https:\/\/www.singlecare.com\/prescription\/xopenex\"><span style=\"font-weight: 400;\">Xopenex<\/span><\/a><span style=\"font-weight: 400;\">, corticosteroids such as <\/span><a href=\"https:\/\/www.singlecare.com\/prescription\/flovent-hfa\"><span style=\"font-weight: 400;\">Flovent<\/span><\/a><span style=\"font-weight: 400;\">, and combination drugs like <\/span><a href=\"https:\/\/www.singlecare.com\/prescription\/symbicort\"><span style=\"font-weight: 400;\">Symbicort<\/span><\/a><span style=\"font-weight: 400;\">.\u00a0\u00a0<\/span><\/p>\n<p><b>RELATED: <\/b><a href=\"https:\/\/www.singlecare.com\/blog\/are-generic-drugs-as-good-as-brand-name-medicines\/\"><b>Are generic drugs as good as brand-name medicines?<\/b><\/a><\/p>\n<h3><span style=\"font-weight: 400;\">Combined cabotegravir and rilpivirine<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">In early 2019, ViiV Healthcare <\/span><a href=\"https:\/\/viivhealthcare.com\/en-gb\/media\/press-releases\/2019\/april\/viiv-healthcare-submits-new-drug-application-to-us-fda-for-the-first-monthly-injectable-two-drug-regimen-of-cabotegravir-and-rilpivirine-for-treatment-of-hiv\/\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">applied<\/span><\/a><span style=\"font-weight: 400;\"> for approval of their monthly injectable, two-drug regimen to treat patients with HIV-1 infection. This is designed to compete with standard three-drug regimens currently used to treat HIV-1 infections. The monthly injection formulation is considered a much more <\/span><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25394037\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">convenient<\/span><\/a><span style=\"font-weight: 400;\"> treatment option for eligible patients, compared to taking a <\/span><a href=\"https:\/\/www.singlecare.com\/prescription\/atripla\"><span style=\"font-weight: 400;\">pill daily<\/span><\/a><span style=\"font-weight: 400;\">.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">In good news for HIV patients, according to <\/span><a href=\"https:\/\/fortune.com\/2019\/07\/08\/monthly-injection-hiv-gsk-viiv\/\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">Fortune<\/span><\/a><span style=\"font-weight: 400;\">, \u201cViiv hopes that the treatment will be approved by the Food and Drug Administration by early next year.\u201d Once approved, the combination drug will be given a brand name.\u00a0<\/span><\/p>\n<p><b>RELATED: <\/b><a href=\"https:\/\/www.singlecare.com\/blog\/news\/fda-approves-biktarvy-hiv\/\"><b>FDA approves Biktarvy for use in HIV regimens<\/b><\/a><\/p>\n<h3><span style=\"font-weight: 400;\">Rybelsus (semaglutide)<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Rybelsus is a new drug from Novo Nordisk, one of the world\u2019s leading diabetes-focused pharmaceutical companies. The new medication was given FDA approval to treat adults with type 2 diabetes in <\/span><a href=\"https:\/\/www.novonordisk-us.com\/media\/news-releases.html?122973\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">September 2019<\/span><\/a><span style=\"font-weight: 400;\">, and became available commercially in December. As manufacturing of the drug transitions from Denmark to the U.S. in 2020, and doctors learn more about its benefits, the drug will likely become widely available.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">When available, it will be offered as a once-daily tablet in 3 mg, 7 mg, and 14 mg doses and is the only glucagon-like peptide-1 (GLP-1) receptor agonist in pill form. The active ingredient, semaglutide, is already available in an <\/span><a href=\"https:\/\/www.singlecare.com\/prescription\/ozempic-1-mg-dose\"><span style=\"font-weight: 400;\">injectable form<\/span><\/a><span style=\"font-weight: 400;\">.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Novo Nordisk is currently working with insurers to keep out-of-pocket costs for insured patients to $10 per month; however, there are reports that it could cost patients up to $772.43 for a 30-day supply.\u00a0<\/span><\/p>\n<p><b>RELATED: <\/b><a href=\"https:\/\/www.singlecare.com\/conditions\/diabetes-medications-treatments\/\" target=\"_blank\" rel=\"noopener noreferrer\"><b>Diabetes medications and treatments<\/b><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Although this is only a snapshot of the new medications that may become commercially available in 2020, it shows exciting things to come\u2014much needed, advanced treatments becoming more readily available. From new, innovative products, to more affordable generics, and convenient treatment alternatives, be sure to check in with your doctor during 2020 in case new medications relevant to your needs become available.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Since 2010 the number of new drugs approved each year by the U.S. Food and Drug Administration (FDA) has increased dramatically, averaging more than 38 new approvals each year compared to previous averages closer to 21. This is great news for patients, as the availability of new drugs and biological products usually means more treatment [&hellip;]<\/p>\n","protected":false},"author":15,"featured_media":7974,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[4589,4114],"tags":[4141],"coauthors":[8861],"class_list":["post-7745","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-drug-info","category-news","tag-fda-approvals","wpautop"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.4 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>New drugs becoming available in 2020 in the United States<\/title>\n<meta name=\"description\" content=\"The FDA approves new drugs each year. Some come right to market, while others are delayed. These are the most exciting ones on the way.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.singlecare.com\/blog\/news\/new-drugs-2020\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New drugs in 2020\" \/>\n<meta property=\"og:description\" content=\"These are the most exciting new medications becoming available this year\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.singlecare.com\/blog\/news\/new-drugs-2020\/\" \/>\n<meta property=\"og:site_name\" content=\"The Checkup\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/singlecare\" \/>\n<meta property=\"article:published_time\" content=\"2020-01-08T14:00:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-04-16T18:51:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.singlecare.com\/blog\/wp-content\/uploads\/2020\/01\/Blog_010820_New_Drugs_2020.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"SingleCare Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"New drugs in 2020\" \/>\n<meta name=\"twitter:description\" content=\"These are the most exciting new medications becoming available this year\" \/>\n<meta name=\"twitter:creator\" content=\"@SingleCare\" \/>\n<meta name=\"twitter:site\" content=\"@SingleCare\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"SingleCare Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/new-drugs-2020\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/new-drugs-2020\\\/\"},\"author\":{\"name\":\"SingleCare Team\",\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/#\\\/schema\\\/person\\\/403ef50a9f402fb9ce49c429659555f5\"},\"headline\":\"Learn about 5 new drugs coming in 2020\",\"datePublished\":\"2020-01-08T14:00:30+00:00\",\"dateModified\":\"2021-04-16T18:51:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/new-drugs-2020\\\/\"},\"wordCount\":1256,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/new-drugs-2020\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/wp-content\\\/uploads\\\/2020\\\/01\\\/Blog_010820_New_Drugs_2020.png\",\"keywords\":[\"FDA approvals\"],\"articleSection\":[\"Drug Info\",\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/new-drugs-2020\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/new-drugs-2020\\\/\",\"url\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/new-drugs-2020\\\/\",\"name\":\"New drugs becoming available in 2020 in the United States\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/new-drugs-2020\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/new-drugs-2020\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/wp-content\\\/uploads\\\/2020\\\/01\\\/Blog_010820_New_Drugs_2020.png\",\"datePublished\":\"2020-01-08T14:00:30+00:00\",\"dateModified\":\"2021-04-16T18:51:45+00:00\",\"description\":\"The FDA approves new drugs each year. Some come right to market, while others are delayed. These are the most exciting ones on the way.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/new-drugs-2020\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/new-drugs-2020\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/new-drugs-2020\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/wp-content\\\/uploads\\\/2020\\\/01\\\/Blog_010820_New_Drugs_2020.png\",\"contentUrl\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/wp-content\\\/uploads\\\/2020\\\/01\\\/Blog_010820_New_Drugs_2020.png\",\"width\":1920,\"height\":1080,\"caption\":\"A bottle spilling out pills represents new drugs in 2020\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/new-drugs-2020\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Learn about 5 new drugs coming in 2020\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/\",\"name\":\"The Checkup, a health blog by SingleCare\",\"description\":\"Read the latest in prescription, wellness, and healthcare news\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/#organization\",\"name\":\"SingleCare\",\"url\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/wp-content\\\/uploads\\\/2020\\\/01\\\/placeholderimage-1.jpg\",\"contentUrl\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/wp-content\\\/uploads\\\/2020\\\/01\\\/placeholderimage-1.jpg\",\"width\":1200,\"height\":630,\"caption\":\"SingleCare\"},\"image\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/singlecare\",\"https:\\\/\\\/x.com\\\/SingleCare\",\"https:\\\/\\\/www.instagram.com\\\/singlecare\\\/?hl=en\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/singlecare\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCd9kiPIjCQw95-2BHCYePKA\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/#\\\/schema\\\/person\\\/403ef50a9f402fb9ce49c429659555f5\",\"name\":\"SingleCare Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7c56ea35da6164263b446caa5424dd8beeb331518803b6043b40932812936fb2?s=96&d=mm&r=gcda8e0f4c5718cb7f68c0ee812f6fafb\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7c56ea35da6164263b446caa5424dd8beeb331518803b6043b40932812936fb2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7c56ea35da6164263b446caa5424dd8beeb331518803b6043b40932812936fb2?s=96&d=mm&r=g\",\"caption\":\"SingleCare Team\"},\"url\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/author\\\/singlecareteam\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"New drugs becoming available in 2020 in the United States","description":"The FDA approves new drugs each year. Some come right to market, while others are delayed. These are the most exciting ones on the way.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.singlecare.com\/blog\/news\/new-drugs-2020\/","og_locale":"en_US","og_type":"article","og_title":"New drugs in 2020","og_description":"These are the most exciting new medications becoming available this year","og_url":"https:\/\/www.singlecare.com\/blog\/news\/new-drugs-2020\/","og_site_name":"The Checkup","article_publisher":"https:\/\/www.facebook.com\/singlecare","article_published_time":"2020-01-08T14:00:30+00:00","article_modified_time":"2021-04-16T18:51:45+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/www.singlecare.com\/blog\/wp-content\/uploads\/2020\/01\/Blog_010820_New_Drugs_2020.png","type":"image\/png"}],"author":"SingleCare Team","twitter_card":"summary_large_image","twitter_title":"New drugs in 2020","twitter_description":"These are the most exciting new medications becoming available this year","twitter_creator":"@SingleCare","twitter_site":"@SingleCare","twitter_misc":{"Written by":"SingleCare Team","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.singlecare.com\/blog\/news\/new-drugs-2020\/#article","isPartOf":{"@id":"https:\/\/www.singlecare.com\/blog\/news\/new-drugs-2020\/"},"author":{"name":"SingleCare Team","@id":"https:\/\/www.singlecare.com\/blog\/#\/schema\/person\/403ef50a9f402fb9ce49c429659555f5"},"headline":"Learn about 5 new drugs coming in 2020","datePublished":"2020-01-08T14:00:30+00:00","dateModified":"2021-04-16T18:51:45+00:00","mainEntityOfPage":{"@id":"https:\/\/www.singlecare.com\/blog\/news\/new-drugs-2020\/"},"wordCount":1256,"commentCount":0,"publisher":{"@id":"https:\/\/www.singlecare.com\/blog\/#organization"},"image":{"@id":"https:\/\/www.singlecare.com\/blog\/news\/new-drugs-2020\/#primaryimage"},"thumbnailUrl":"https:\/\/www.singlecare.com\/blog\/wp-content\/uploads\/2020\/01\/Blog_010820_New_Drugs_2020.png","keywords":["FDA approvals"],"articleSection":["Drug Info","News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.singlecare.com\/blog\/news\/new-drugs-2020\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.singlecare.com\/blog\/news\/new-drugs-2020\/","url":"https:\/\/www.singlecare.com\/blog\/news\/new-drugs-2020\/","name":"New drugs becoming available in 2020 in the United States","isPartOf":{"@id":"https:\/\/www.singlecare.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.singlecare.com\/blog\/news\/new-drugs-2020\/#primaryimage"},"image":{"@id":"https:\/\/www.singlecare.com\/blog\/news\/new-drugs-2020\/#primaryimage"},"thumbnailUrl":"https:\/\/www.singlecare.com\/blog\/wp-content\/uploads\/2020\/01\/Blog_010820_New_Drugs_2020.png","datePublished":"2020-01-08T14:00:30+00:00","dateModified":"2021-04-16T18:51:45+00:00","description":"The FDA approves new drugs each year. Some come right to market, while others are delayed. These are the most exciting ones on the way.","breadcrumb":{"@id":"https:\/\/www.singlecare.com\/blog\/news\/new-drugs-2020\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.singlecare.com\/blog\/news\/new-drugs-2020\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.singlecare.com\/blog\/news\/new-drugs-2020\/#primaryimage","url":"https:\/\/www.singlecare.com\/blog\/wp-content\/uploads\/2020\/01\/Blog_010820_New_Drugs_2020.png","contentUrl":"https:\/\/www.singlecare.com\/blog\/wp-content\/uploads\/2020\/01\/Blog_010820_New_Drugs_2020.png","width":1920,"height":1080,"caption":"A bottle spilling out pills represents new drugs in 2020"},{"@type":"BreadcrumbList","@id":"https:\/\/www.singlecare.com\/blog\/news\/new-drugs-2020\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.singlecare.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Learn about 5 new drugs coming in 2020"}]},{"@type":"WebSite","@id":"https:\/\/www.singlecare.com\/blog\/#website","url":"https:\/\/www.singlecare.com\/blog\/","name":"The Checkup, a health blog by SingleCare","description":"Read the latest in prescription, wellness, and healthcare news","publisher":{"@id":"https:\/\/www.singlecare.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.singlecare.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.singlecare.com\/blog\/#organization","name":"SingleCare","url":"https:\/\/www.singlecare.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.singlecare.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.singlecare.com\/blog\/wp-content\/uploads\/2020\/01\/placeholderimage-1.jpg","contentUrl":"https:\/\/www.singlecare.com\/blog\/wp-content\/uploads\/2020\/01\/placeholderimage-1.jpg","width":1200,"height":630,"caption":"SingleCare"},"image":{"@id":"https:\/\/www.singlecare.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/singlecare","https:\/\/x.com\/SingleCare","https:\/\/www.instagram.com\/singlecare\/?hl=en","https:\/\/www.linkedin.com\/company\/singlecare\/","https:\/\/www.youtube.com\/channel\/UCd9kiPIjCQw95-2BHCYePKA"]},{"@type":"Person","@id":"https:\/\/www.singlecare.com\/blog\/#\/schema\/person\/403ef50a9f402fb9ce49c429659555f5","name":"SingleCare Team","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/7c56ea35da6164263b446caa5424dd8beeb331518803b6043b40932812936fb2?s=96&d=mm&r=gcda8e0f4c5718cb7f68c0ee812f6fafb","url":"https:\/\/secure.gravatar.com\/avatar\/7c56ea35da6164263b446caa5424dd8beeb331518803b6043b40932812936fb2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7c56ea35da6164263b446caa5424dd8beeb331518803b6043b40932812936fb2?s=96&d=mm&r=g","caption":"SingleCare Team"},"url":"https:\/\/www.singlecare.com\/blog\/author\/singlecareteam\/"}]}},"_links":{"self":[{"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/posts\/7745","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/comments?post=7745"}],"version-history":[{"count":0,"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/posts\/7745\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/media\/7974"}],"wp:attachment":[{"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/media?parent=7745"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/categories?post=7745"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/tags?post=7745"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/coauthors?post=7745"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}